Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

BIO-TECHNE (TECH) Long-Term Debt Issuances: 2014-2025

Historic Long-Term Debt Issuances for BIO-TECHNE (TECH) over the last 2 years, with Jun 2025 value amounting to $66.0 million.

  • BIO-TECHNE's Long-Term Debt Issuances was N/A to $66.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $329.0 million, marking a year-over-year change of. This contributed to the annual value of $104.0 million for FY2025, which is 53.78% down from last year.
  • According to the latest figures from Q2 2025, BIO-TECHNE's Long-Term Debt Issuances is $66.0 million, which was up 73.68% from $38.0 million recorded in Q1 2025.
  • In the past 5 years, BIO-TECHNE's Long-Term Debt Issuances ranged from a high of $449.7 million in Q3 2022 and a low of $10.0 million during Q3 2021.
  • Its 2-year average for Long-Term Debt Issuances is $99.8 million, with a median of $66.0 million in 2025.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first soared by 4,396.61% in 2022, then slumped by 64.42% in 2023.
  • Over the past 4 years, BIO-TECHNE's Long-Term Debt Issuances (Quarterly) stood at $40.0 million in 2021, then spiked by 4,396.61% to $449.7 million in 2022, then plummeted by 64.42% to $65.0 million in 2023, then reached $66.0 million in 2025.
  • Its Long-Term Debt Issuances was $66.0 million in Q2 2025, compared to $38.0 million in Q1 2025 and $65.0 million in Q4 2023.